HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakanishi, N. Articles by Tatara, K. Search for Related Content PubMed PubMed Citation Articles by Nakanishi, N. Articles by Tatara, K. Social Bookmarking                What's this?

Serum -Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men

¹ Department of Social and Environmental Medicine F2, Course of Social Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
² Japan Labor and Welfare Association, Tokyo, Japan

Address correspondence and reprint requests to Noriyuki Nakanishi, Department of Social and Environmental Medicine, Course of Social Medicine, Osaka University Graduate School of Medicine F2, 2-2 Yamada-oka, Suita-shi, Osaka 565-0871, Japan. E-mail: noriyuki{at}pbhel.med.osaka-u.ac.jp

OBJECTIVE—To investigate the association between serum -glutamyltransferase (GGT) and risk of metabolic syndrome and type 2 diabetes in Japanese male office workers.

RESEARCH DESIGN AND METHODS—This study included 2,957 metabolic syndrome-free men and 3,260 nondiabetic men aged 35–59 years who did not have medication for hepatitis, alanine aminotransferase (ALT) levels higher than three times the upper limit of the reference range, or a history of cardiovascular disease at study entry. Subjects were reexamined at periodic annual health examinations over a 7-year period. We used a modified National Cholesterol Education Program definition of metabolic syndrome with BMI instead of waist circumference and the revised criteria of the American Diabetes Association for type 2 diabetes.

RESULTS—With adjustment for age, family history of diabetes, BMI, alcohol intake, cigarette smoking, regular physical activity (fasting plasma glucose for the risk of type 2 diabetes), and white blood cell (WBC) count, the risk of metabolic syndrome and type 2 diabetes increased in correlation with the levels of serum GGT, ALT, aspartate aminotransferase (AST), and alkaline phosphatase. Additional adjustment for all of the other liver enzymes attenuated these associations, but serum GGT remained a significant risk factor for the risk of both metabolic syndrome and type 2 diabetes (P for trend <0.001 for both). Top one-fifth versus bottom one-fifth relative risks of metabolic syndrome and type 2 diabetes were 2.23 (95% CI 1.51–3.30) and 2.44 (1.34–4.46), respectively.

CONCLUSIONS—These results indicate that serum GGT may be an important predictor for developing metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

Abbreviations: ALT, alanine aminotransferase • AST, aspartate aminotransferase • CHD, coronary heart disease • GGT, -glutamyltransferase • NCEP, National Cholesterol Education Program • WBC, white blood cell

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. K. Sato, T. Hayashi, Y. Nakamura, N. Harita, T. Yoneda, G. Endo, and H. Kambe Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes: The Kansai Healthcare Study Diabetes Care, June 1, 2008; 31(6): 1230 - 1236. [Abstract] [Full Text] [PDF]

				E. S. Ford, M. B. Schulze, M. M. Bergmann, C. Thamer, H.-G. Joost, and H. Boeing Liver Enzymes and Incident Diabetes: Findings from the European Prospective Investigation Into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes Care, June 1, 2008; 31(6): 1138 - 1143. [Abstract] [Full Text] [PDF]

				A Fraser, S Ebrahim, G Davey Smith, and D A Lawlor The associations between height components (leg and trunk length) and adult levels of liver enzymes J. Epidemiol. Community Health, January 1, 2008; 62(1): 48 - 53. [Abstract] [Full Text] [PDF]

				A. Kotronen and H. Yki-Jarvinen Fatty Liver: A Novel Component of the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38. [Abstract] [Full Text] [PDF]

				N. H. Cho, H. C. Jang, S. H. Choi, H. R. Kim, H. K. Lee, J. C.N. Chan, and S. Lim Abnormal Liver Function Test Predicts Type 2 Diabetes: A community-based prospective study Diabetes Care, October 1, 2007; 30(10): 2566 - 2568. [Full Text] [PDF]

				P. Andre, B. Balkau, S. Vol, M. A. Charles, E. Eschwege, and on behalf of the DESIR Study Group {gamma}-Glutamyltransferase Activity and Development of the Metabolic Syndrome (International Diabetes Federation Definition) in Middle-Aged Men and Women: Data From the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort Diabetes Care, September 1, 2007; 30(9): 2355 - 2361. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, L. E. Wagenknecht, A. Festa, R. B. D'Agostino Jr., and S. M. Haffner Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort: The Insulin Resistance Atherosclerosis Study Diabetes Care, July 1, 2007; 30(7): 1819 - 1827. [Abstract] [Full Text] [PDF]

				D. S. Lee, J. C. Evans, S. J. Robins, P. W. Wilson, I. Albano, C. S. Fox, T. J. Wang, E. J. Benjamin, R. B. D'Agostino, and R. S. Vasan Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 127 - 133. [Abstract] [Full Text] [PDF]

				S. Ryu, Y. Chang, D.-I. Kim, W. S. Kim, and B.-S. Suh {gamma}-Glutamyltransferase as a Predictor of Chronic Kidney Disease in Nonhypertensive and Nondiabetic Korean Men Clin. Chem., January 1, 2007; 53(1): 71 - 77. [Abstract] [Full Text] [PDF]

				R. Simo, A. Lecube, J. Genesca, J. I. Esteban, and C. Hernandez Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection. Diabetes Care, November 1, 2006; 29(11): 2462 - 2466. [Abstract] [Full Text] [PDF]

				S. G. Wannamethee, A. G. Shaper, L. Lennon, and P. H. Whincup Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men Diabetes Care, December 1, 2005; 28(12): 2913 - 2918. [Abstract] [Full Text] [PDF]

				G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, R. Tessari, L. Zenari, and G. Falezza Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Diabetes, December 1, 2005; 54(12): 3541 - 3546. [Abstract] [Full Text] [PDF]

				A. J.G. Hanley, K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino Jr, and S. M. Haffner Liver Markers and Development of the Metabolic Syndrome: The Insulin Resistance Atherosclerosis Study Diabetes, November 1, 2005; 54(11): 3140 - 3147. [Abstract] [Full Text] [PDF]

				E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer, and the Vorarlberg Health Monitoring and Promotion Pro {gamma}-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults Circulation, October 4, 2005; 112(14): 2130 - 2137. [Abstract] [Full Text] [PDF]

				D. A. Lawlor, N. Sattar, G. D. Smith, and S. Ebrahim The Associations of Physical Activity and Adiposity with Alanine Aminotransferase and Gamma-Glutamyltransferase Am. J. Epidemiol., June 1, 2005; 161(11): 1081 - 1088. [Abstract] [Full Text] [PDF]